中牧股份(600195.SH):黃岡動物藥品廠獲獸藥產品批准文號批件
格隆匯5月12日丨中牧股份(600195.SH)公佈,根據《獸藥管理條例》和《獸藥產品批准文號管理辦法》等有關規定,經農業農村部審查,准予公司黃岡動物藥品廠生產布他磷原料藥。
布他磷是有機磷補充劑的主要成分,具有改善動物應激反應、促進新陳代謝、增強免疫的效果,在安全性、藥效方面優勢突出,符合“減抗”、“限抗”的行業監管政策要求,給藥途徑適用於集約化養殖模式。此次獲得該獸藥產品批准文號將進一步豐富公司獸藥產品序列,對提升市場競爭力產生積極影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.